Retatrutide (Reta) is a synthetic peptide and triple agonist of the GLP-1, GIP, and glucagon receptors. In research contexts, it has been studied for its potential effects on glucose regulation, energy balance, and metabolic function. Investigations explore its influence on appetite modulation, insulin sensitivity, and related endocrine pathways.
All peptides come as a lyophilised powder that needs to be reconstituted with bacteriostatic water.
